EMERALD: Previous ARV Use and Virologic Failure Has No Impact on Efficacy of Switch From Boosted PI Plus FTC/TDF to DRV/COBI/FTC/TAF in Patients With Virologic Suppression
Conference Capsule - Rates of virologic rebound or virologic efficacy at Week 48 similar across subgroups of patients without history of DRV RAMs or virologic failure on DRV. (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - March 9, 2018 Category: Infectious Diseases Source Type: research
D:A:D Study: Development of Chronic Kidney Disease Increases Risk of Serious Clinical Events and Death in Patients With HIV
Conference Capsule - Analysis suggests modifiable risk factors play a key role in increased morbidity and mortality following CKD diagnosis. (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - March 9, 2018 Category: Infectious Diseases Source Type: research
ANDES: ART Initiation With DRV/RTV Plus 3TC Achieves Similar Efficacy to DRV/RTV Plus 3TC/TDF at 48 Weeks
Conference Capsule - Boosted PI –based dual therapy provides similar safety and efficacy through 48 weeks compared with boosted PI–based triple therapy in treatment-naive patients including those with baseline HIV-1 RNA> 100,000 copies/mL. (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - March 8, 2018 Category: Infectious Diseases Source Type: research
Contemporary Management of HIV: How Aging Affects ART Management
Slideset - In this downloadable slideset, Expert Faculty review key data on managing aging patients with HIV. (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - March 7, 2018 Category: Infectious Diseases Source Type: research
Study 380-1844: Switch From DTG/ABC/3TC to BIC/FTC/TAF Noninferior to Continued DTG/ABC/3TC at Week 48 in Virologically Suppressed Adults
Conference Capsule - Overall efficacy and safety between the 2 INSTI-based, fixed-dose regimens comparable after 48 weeks. (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - March 7, 2018 Category: Infectious Diseases Source Type: research
Expert Guidance on Switching ART in Virologically Suppressed Patients
Tool - Use this Interactive Decision Support Tool to get treatment recommendations from Joseph J. Eron, Jr., MD; Paul E. Sax, MD; Babafemi Taiwo, MBBS; Timothy J. Wilkin, MD, MPH; and Brian Wood, MD, for your virologically suppressed patients requiring a switch in ART. (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - March 6, 2018 Category: Infectious Diseases Source Type: research
HIV Alert: Options for Integrase Inhibitor Therapy Following Recent Drug Approvals
Slideset - In this downloadable slideset, Paul E. Sax, MD, and Brian R. Wood, MD, provide expert insight into the use of recently-approved INSTI regimens and discuss how these regimens fit into the current HIV treatment landscape. (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - March 6, 2018 Category: Infectious Diseases Source Type: research
Clinical Impact of New Data From CROI 2018
Slideset - Expert faculty members summarize key studies from this important annual conference. (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - March 2, 2018 Category: Infectious Diseases Source Type: research
HIV Alert: ART Considerations for Aging Patients
Audio - Listen to downloadable audio from a series of live Webinars by Eric S. Daar, MD, and David A. Wohl, MD, in which ART selection and general management for older patients with HIV are discussed and audience questions on these subjects are addressed. (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - February 14, 2018 Category: Infectious Diseases Source Type: research
Contemporary Management of HIV: ART Strategies in Advanced Clinical Development for 2018
Slideset - In this downloadable slideset, Paul E. Sax, MD, and Program Director Joseph J. Eron, Jr., MD, review key data on emerging investigational agents and strategies. (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - February 12, 2018 Category: Infectious Diseases Source Type: research
Contemporary Management of HIV: How Common Comorbidities Affect ART Management
Slideset - In this downloadable slideset, expert faculty review key data and offer important guidance on managing HIV treatment in patients with frequently encountered comorbidities, including cardiovascular disease, osteopenia, and HCV coinfection. (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - February 12, 2018 Category: Infectious Diseases Source Type: research
HIV Alert: ART Considerations for Aging Patients
Slideset - In this downloadable slideset, Eric S. Daar, MD, and David A. Wohl, MD, provide expert recommendations for older patients with HIV, both in terms of ART selection and general management. (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - February 12, 2018 Category: Infectious Diseases Source Type: research
Contemporary Management of HIV: Evolving Approaches to ART Modification
Slideset - In this downloadable slideset, Babafemi Taiwo, MBBS, and Program Director Joseph J. Eron, Jr., MD, review key data and optimal approaches for modifying ART in patients who are virologically suppressed or have experienced treatment failure. (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - February 12, 2018 Category: Infectious Diseases Source Type: research
Contemporary Management of HIV: Selecting First-line ART
Slideset - In this downloadable slideset, Program Chair Joseph J. Eron, Jr., MD, and Daniel R. Kuritzkes, MD, review key data and expert guidance on initiating treatment in HIV-infected patients. (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - January 26, 2018 Category: Infectious Diseases Source Type: research
HIV Alert: Emerging Updates on Dual Therapy
Audio - Listen to downloadable audio from a series of live Webinars by Joseph J. Eron, Jr., MD, and Babafemi Taiwo, MBBS, in which the use of a recently approved dual-therapy regimen and data surrounding investigational 2-drug regimens are discussed and audience questions on these subjects are addressed. (Source: Clinical Care Options HIV)
Source: Clinical Care Options HIV - January 18, 2018 Category: Infectious Diseases Source Type: research
